Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016;1(3):11-21.

Neurokinin 1 and opioid receptors: relationships and interactions in nervous system

Jie Xiao  1   2 , Si Zeng  3 , Xiangrui Wang  1 , Hasan Babazada  2 , Zhanchun Li  1 , Renyu Liu  2 , Weifeng Yu  1
Affiliations

Neurokinin 1 and opioid receptors: relationships and interactions in nervous system

Jie Xiao et al. Transl Perioper Pain Med. 2016.

Abstract

Opioid receptors and neurokinin 1 receptor (NK1R) are found highly expressed in the central nervous system. The co-localization of these two kinds of receptors suggests that they might interact with each other in both the transmission and modulation of the pain signal. In this review, we explore the relationships between opioid receptors and NK1R. Substance P (SP) plays a modulatory role in the pain transmission by activating the NK1R. Opioid receptor activation can inhibit SP release. NK1R is found participating in the mechanisms of the side effects of the opioids, including opioid analgesic tolerance, hyperalgesia, anxiety behaviors of morphine reward and opioids related respiratory depression. A series of compounds such as NK1R antagonists and ligands works on both mu/delta opioid receptor (MOR/DOR) and NK1R were synthesized as novel analgesics that enhance the clinical pain management efficacy and reduce the dosage and side effects. The current status of these novel ligands and the limitations are discussed in this review. Although the working mechanisms of these ligands remained unclear, they could be used as research tool for developing novel analgesic drugs in the future.

Keywords: Central nervous system; Neurokinin 1 receptor; Opioid receptors; Opioids; Substance P.

PubMed Disclaimer

Conflict of interest statement

Conflict Interests Disclosure: The authors have no conflicting interests to disclose.

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Breivik H, Borchgrevink PC, Allen SM, et al. Assessment of pain. Br J Anaesth. 2008;101:17–24. - PubMed
    1. Debono DJ, Hoeksema LJ, Hobbs RD. Caring for patients with chronic pain: pearls and pitfalls. J Am Osteopath Assoc. 2013;113:620–7. - PubMed
    1. Besson JM. The neurobiology of pain. Lancet. 1999;353:1610–5. - PubMed
    1. Millan MJ. Descending control of pain. Prog Neurobiol. 2002;66:355–474. - PubMed
    1. Pinto M, Sousa M, Lima D, Tavares I. Participation of mu-opioid, GABA(B), and NK1 receptors of major pain control medullary areas in pathways targeting the rat spinal cord: implications for descending modulation of nociceptive transmission. The Journal of comparative neurology. 2008;510:175–87. - PubMed

LinkOut - more resources